Birtas Atesoglu, E. Et Al. 2023. Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data.. Hematological oncology , vol.41 , 663-673.

Birtas Atesoglu, E., Gulbas, Z., Uzay, A., Ozcan, M., Ozkalemkas, F., Dal, M. S., ... Kalyon, H.(2023). Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data.. Hematological oncology , vol.41, 663-673.

Birtas Atesoglu, Elif Et Al. "Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data.," Hematological oncology , vol.41, 663-673, 2023

Birtas Atesoglu, Elif B. Et Al. "Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data.." Hematological oncology , vol.41, pp.663-673, 2023

Birtas Atesoglu, E. Et Al. (2023) . "Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data.." Hematological oncology , vol.41, pp.663-673.

@article{article, author={Elif Birtas Atesoglu Et Al. }, title={Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data.}, journal={Hematological oncology}, year=2023, pages={663-673} }